Founder & CEO
COO & CFO
Scott Greenwald, Ph.D.
CS/VP of Research
paul j. manberg, ph.d.
VP of Clinical & Regulatory Affairs
VP of Corporate Strategy
Board of Directors
John J. O’Connor serves as Chairman of the HDAI Board. Mr. O’Connor is the former vice chairman of services for PricewaterhouseCoopers LLP. Prior to his retirement in 2006, O’Connor was responsible for the firm’s business lines, with combined revenues of $7 billion and 28,000 employees in 90 offices. During his career at PricewaterhouseCoopers, O'Connor also served as the leader of the firm’s U.S. audit practice, and prior to this, was the managing partner of the firm’s Boston office. He was a partner for 24 of his 33 years at PricewaterhouseCoopers.
O’Connor serves on several corporate Boards, including Abt Associates, LeMaitre Vascular, Inc. and mTuitive, Inc., as well as on several non-profit Boards, including the Dana-Farber Cancer Institute and the Harvard Medical Collaborative.
O’Connor holds a B.A. from Suffolk University in Boston and an executive MBA from the Amos Tuck School at Dartmouth College. He also graduated from the Harvard Business School's Leadership in Professional Service Firms program.d
Edwin M. Kania, Jr.
Edwin M. Kania, Jr. is a co-founder of HDAI and serves on its Board. Mr. Kania is the co-founder of Flagship Pioneering, a leading life sciences venture firm. He was the firm’s Chairman between 2001 and 2014, and continues as Managing Partner for the Flagship funds raised during that period. Kania has 35 years of experience in the venture capital industry. Prior to co-founding Flagship in 2000, he served as Managing Partner at OneLiberty Ventures and as a General Partner at its predecessor firm, Morgan, Holland Ventures.
Throughout his professional career, Kania has operated as an investor and active partner to entrepreneurs in company building. His direct investment experience covers over 100 companies. In addition, he has been intimately involved in the launch and development of nearly twenty companies as the founding, lead or co-lead investor, and on occasion has assumed operating roles in support of management. The total value of the companies in which Kania has participated as founding or lead investor exceeds $10 billion. Kania presently serves on the Board of several private companies and has been a Director for numerous publicly-traded and private companies. He has also been a long-time Director of MassBio, a not-for-profit organization representing the Massachusetts biopharmaceutical industry, and is a member of Harvard Partners’ Innovation Advisory Board.
Kania earned his undergraduate degree in physics from Dartmouth College and his MBA from Harvard Business School.
Kenneth A. Froot
Kenneth A Froot is a co-founder of HDAI and serves on its Board. He is the André R. Jakurski Professor of Business Administration, Emeritus, at Harvard University's Graduate School of Business Administration. His prior appointments at Harvard include HBS Director of Research, the Industrial Bank of Japan Professorship in Finance, and the Thomas Henry Carroll-Ford Foundation Visitor's Chair. Prior to coming to Harvard, he held the Ford International Development Chair at MIT, where he joined the faculty in 1986. He has taught numerous courses in economics and finance, including more recently Capital Markets, International Finance, and Risk Management.
Professor Froot is also a founding partner of FDO Partners, LLC, State Street Associates and MKT MediaStats, firms producing investment and knowledge resources for global investors.
Professor Froot received his B.A. from Stanford University and his Ph.D. from the University of California at Berkeley. He spent the 1988-1989 academic year as an Olin Fellow at the National Bureau of Economic Research, where he served as Chair of the NBER’s Insurance Group. His research on a wide range of topics in finance, risk management, and international markets has been published in many journals and books.